Guidance
Update information
October 2019: We have reviewed the evidence and made new recommendations on antimicrobial prescribing for adults with a diabetic foot infection. These recommendations are marked [2019].
Recommendations marked [2015] last had an evidence review in 2015. In some cases, minor changes have been made to the wording to bring the language and style up to date, without changing the meaning.
August 2015: This guidance updates and replaces NICE guidelines CG10 (published January 2004) and CG119 (published March 2011).
Recommendations marked [2011] last had an evidence review in 2011.
Minor changes since publication
September 2024: We updated table 2 'Additional antibiotic choices if Pseudomonas aeruginosa suspected or confirmed' to reflect the new safety advice on fluoroquinolones.
January 2023: We reviewed recent evidence and decided that no changes were needed to our guidance on risk assessment tools for diabetic foot problems and frequency of diabetic foot reviews. Recommendations are marked [2023] if the evidence was reviewed.
January 2016: Recommendation 1.3.6 has been updated to clarify the risk factors for and stratification of risk of developing a diabetic foot problem.
December 2015: Recommendation 1.3.14 has been amended to refer to the updated NICE guideline on type 2 diabetes in adults.
ISBN: 978-1-4731-4945-8